(@sjlondon1)

AoU Research Priorities Use Cases

What are the health impacts of cannabis use in the US population?

Cannabis use is increasing with greater legalization; data on health consequences are limited. AllofUs could enable a comprehensive study of health impacts of cannabis use. Sufficient questions to characterize past and current use of the range of cannabis products would need to be added. Health outcome data from questionnaires and medical record linkage already being collected could be used. Existing biospecimens could... more »

Voting

19 votes
Ideate
(@eric.austin)

AoU Research Priorities Use Cases

Determine the long term pulmonary and cardiovascular consequences of premature birth from childhood into adulthood

This study will enroll premature infants at the time of birth, in order to follow the children in phases from birth to adulthood to test the central hypothesis that premature birth permanently impairs normal pulmonary and cardiovascular development, resulting in the development of common and rare cardiopulmonary conditions which reduce cardiopulmonary function throughout life. Phase one will study children from birth... more »

Voting

17 votes
Ideate
(@mary.salvatore)

AoU Research Priorities Use Cases

What is the natural progression of Idiopathic Pulmonary Fibrosis on Chest CT?

IPF patients become aware of disease when becoming symptomatic with cough and dyspnea. By then, CT often shows advanced fibrosis. It is important to know how long the patient had changes on CT before becoming symptomatic and finding clues to predict progression versus stability - for ex. the size of the pulmonary artery. This becomes more important now that the FDA has approved 2 medications which slow the progression... more »

Voting

5 votes
Ideate
(@mary.salvatore)

AoU Research Priorities Use Cases

What is the natural progression of Idiopathic Pulmonary Fibrosis on Chest CT?

IPF patients become aware of disease when becoming symptomatic with cough and dyspnea. By then, CT often shows advanced fibrosis. It is important to know how long the patient had changes on CT before becoming symptomatic and finding clues to predict progression versus stability - for ex. the size of the pulmonary artery. This becomes more important now that the FDA has approved 2 medications which slow the progression... more »

Voting

5 votes
Ideate